B cells also express CD40, and while their contribution of antibodies against tumor control remains controversial, there are data suggesting that CD40-mediated activation of B cells increases their antigen-presenting capabilities and modulates cytokine production, possibly supporting effector CD4+ T cell responses within tumors. The gene discussed is CD4; the disease is neoplasm.